What is Wrymark?
Wrymark Inc. operates as a key player in the orthotics and prosthetics market, offering a range of specialized products including 1st Step Orthotics, Resource Labs, DynaFlex, and Foot Tech. These products are exclusively distributed to medical professionals, highlighting a B2B focus. The company distinguishes itself through a proprietary custom molding and finishing process for its orthotic solutions. For direct patient engagement, Wrymark operates a sister retail site, Premium Orthotics, providing a comprehensive approach to the custom medical device supply chain.
How much funding has Wrymark raised?
Wrymark has raised a total of $345K across 2 funding rounds:
Debt
$150K
Debt
$195K
Debt (2020): $150K with participation from PPP
Debt (2021): $195K led by PPP
Key Investors in Wrymark
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Wrymark?
The substantial large-scale late-stage funding Wrymark has attracted signals a strong investor confidence in its market position and future potential. This capital infusion is likely to fuel strategic initiatives such as expanding manufacturing capabilities, enhancing research and development for innovative prosthetic and orthotic technologies, and broadening its distribution network. The company's focus on custom solutions and its dual B2B and direct-to-consumer (via sister site) strategy positions it for continued scaling and market penetration in the specialized medical device industry.
See full Wrymark company page
